Martin Forrest | VP of IR & Corporate Communications |
Aron Knickerbocker | President and CEO |
Bryan Irving | Chief Scientific Officer |
David Smith | Chief Financial Officer |
Dr. Helen Collins | Chief Medical Officer |
Chris Shibutani | Cowen |
Michael Schmidt | Guggenheim |
Jonathan Chang | SVB Leerink |
Maryana Breitman | Goldman Sachs |
Turner Kufe | JPMorgan |
Salveen Richter | Goldman Sachs |
Welcome to the Five Prime Therapeutics First Quarter 2019 Earnings Call.
As a reminder, this conference call is being recorded. I'd like now to introduce your host for today's conference, Martin Forrest, Vice President, Investor Relations and Corporate Communications.
You may begin your conference.
Thank you, Lee.